JPMorgan Healthcare Leaders ETF
JDOC
2 hedge funds and large institutions have $4.71M invested in JPMorgan Healthcare Leaders ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
12.74% less ownership
Funds ownership: 80.67% → 67.94% (-13%)
23% less capital invested
Capital invested by funds: $6.12M → $4.71M (-$1.41M)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$1.14M |
| 2 |
KF
Krilogy Financial
St. Louis,
Missouri
|
-$517K |
JDOC Hedge Fund Activity: Q1 2025 in Review
2 of the 7,465 institutional investors tracked by Wall St. Rank reported a position in JPMorgan Healthcare Leaders ETF (JDOC) for Q1 2025, worth a combined $4.71M — down 23% from $6.12M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of JDOC and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $6.43K. The largest seller was Jane Street, exiting entirely with an estimated $1.14M sold.
- 2 institutional investors held JPMorgan Healthcare Leaders ETF (JDOC) as of Q1 2025, down from 3 in Q4 2024.
- Funds reported $4.71M of JPMorgan Healthcare Leaders ETF stock for Q1 2025, down 23% quarter-over-quarter.
- 1 fund opened new JPMorgan Healthcare Leaders ETF positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest JPMorgan Healthcare Leaders ETF buyer in Q1 2025 was Royal Bank of Canada, an estimated $6.43K added.
- The largest JPMorgan Healthcare Leaders ETF seller in Q1 2025 was Jane Street, an estimated $1.14M sold.
Based on aggregated 13F filings for Q1 2025.